MATA NATHAN L. (Chief Scientific Officer) sold 27.3% of their position (1K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $155.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 5/5/2026ACC: 0001193125-26-206456
Officer· Chief Scientific Officer
Since Mar 2026
-1K
Net shares
Net seller
$155.6K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
1K disposed
Non-Derivative Transactions5
American depositary share
Direct
Shares
−32.00
Price / share
$153.50
Trade value
$4.91K
% of position
0.9%
5/4/2026
3.67K→3.63K
American depositary share
Direct
Shares
−236.00
Price / share
$154.24
Trade value
$36.40K
% of position
6.5%
5/4/2026
3.63K→3.40K
American depositary share
Direct
Shares
−325.00
Price / share
$155.21
Trade value
$50.44K
% of position
9.6%
5/4/2026
3.40K→3.07K
American depositary share
Direct
Shares
−235.00
Price / share
$156.57
Trade value
$36.79K
% of position
7.6%
5/4/2026
3.07K→2.84K
American depositary share
Direct
Shares
−172.00
Price / share
$157.49
Trade value
$27.09K
% of position
6.1%
5/4/2026
2.84K→2.67K
Total
Net shares
−1K
Net value
-$155.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 5/4/2026 | S · Sale | −32.00 | $153.50 | $4.91K | 0.9% | 3.67K | 3.63K |
| American depositary share Direct | 5/4/2026 | S · Sale | −236.00 | $154.24 | $36.40K | 6.5% | 3.63K | 3.40K |
| American depositary share Direct | 5/4/2026 | S · Sale | −325.00 | $155.21 | $50.44K | 9.6% | 3.40K | 3.07K |
| American depositary share Direct | 5/4/2026 | S · Sale | −235.00 | $156.57 | $36.79K | 7.6% | 3.07K | 2.84K |
| American depositary share Direct | 5/4/2026 | S · Sale | −172.00 | $157.49 | $27.09K | 6.1% | 2.84K | 2.67K |
| Total | −1K | -$155.64K | ||||||
Derivative Transactions0
No derivative transactions reported